Skip to main content
Equibles
BOLD logo

BOLD · Boundless Bio, Inc. · Metrics

Track BOLD — free

Use BOLD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BOLD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.41 +0.00 (+0.00%) At close · Oct 27
Rebalance outlook locked
Market Cap
$54.82M
Shares
22.75M
Volume · Oct 27 91.09K Avg daily vol (3M) 176.49K

BOLD metrics

66 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.41
Market cap
$54.82M

Price action

20 metrics
Price change (1W)
+4.3%
Price change (30D)
-7.7%
Price change (3M)
-2.8%
Price change (6M)
+63.9%
Price change (YTD)
+100.8%
Price change (1Y)
+65.1%
Trailing year
Price change (5Y)
—
52-week high
$3.00
52-week low
$1.05
Change from 52-week high
-19.7%
Change from 52-week low
+129.5%
Annualized volatility
99.6%
Annualized volatility (3M)
33.5%
Beta
0.0
RSI (14D)
40.7
Price vs SMA 50
-10.5%
Price vs SMA 200
+27.6%
Avg volume (3M)
176,956
Relative volume
0.3
Average dollar volume
$473,986

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
22.75M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.8
reciprocal yield 120.3%
FCF yield
-103.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-116.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$68.01M
Net income (TTM)
−$64.01M
Trailing 12 months
Diluted EPS (TTM)
$-2.85
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-3.03
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-2.86
Operating cash flow per diluted share (TTM)
$-2.51
Free cash flow per diluted share (TTM)
$-2.53
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$1.97
Stock compensation per diluted share (TTM)
$0.32
Book value per share
$4.40

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.4%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-97.0%
Return on assets
-86.8%
Debt / equity
0.0
Current ratio
9.5
EBITDA (TTM)
—
Free cash flow (TTM)
−$56.73M
Quick ratio
9.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$72.63M
Latest balance sheet
Cash & equivalents
$20.21M
Total assets
$73.74M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$56.25M
Capital expenditures (TTM)
$485,000
R&D (TTM)
$44.20M
SG&A (TTM)
—
Stock compensation (TTM)
$7.23M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
40
13F filer change QoQ
+4
Institutional ownership
67.3%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
36.2%
Private-fund adviser ownership
34.9%
Active holders' share change QoQ
+88.9%
Holder tenure
3.9
Price vs estimated holder cost
+61.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.4%

Short interest

3 metrics
Short interest
3.5%
Latest settlement · 4.6 days to cover
Days to cover
4.6d
Short-squeeze score
45 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1782303 CUSIP 10170A100 13F (30d) 1 filings 1 filers Visit website Investor relations